Eterna Therapeutics Inc. (ERNA)

Eterna Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	9.21	11.67	15.54	16.99	1.63	3.26
Cash & Cash Equivalents	9.21	11.67	15.54	16.99	1.63	3.26
Cash Growth	-2.96%	-24.91%	-8.50%	942.02%	-49.98%	26.02%
Receivables	0.35	0.43	0.95	0.68	0	1.2
Other Current Assets	-3.4	-2.5	-2.81	1.1	0.1	1.62
Total Current Assets	6.16	9.6	13.68	18.77	1.73	6.07
Property, Plant & Equipment	37.23	33.27	1.27	3.24	2.69	4.92
Long-Term Investments	0	0	0.06	1	0	0.15
Goodwill and Intangibles	2.04	2.04	2.04	2.04	2.04	2.61
Other Long-Term Assets	4.22	4.22	5.23	6.48	6.44	0.37
Total Long-Term Assets	43.49	39.53	8.6	12.76	11.17	8.06
Total Assets	49.66	49.13	22.28	31.53	12.91	14.13
Accounts Payable	2.83	2.27	4.58	1.76	1.28	0.84
Deferred Revenue	0.53	0.58	0	0	0	0.46
Current Debt	2.87	2.22	0.3	0.43	0.8	3.17
Other Current Liabilities	1.53	1.5	2.78	1.5	1.05	1.63
Total Current Liabilities	7.77	6.57	7.65	3.68	3.13	6.1
Long-Term Debt	44.58	39.63	0.89	2.3	2.1	2.91
Other Long-Term Liabilities	0.72	0.7	1.63	0.05	0.02	0.03
Total Long-Term Liabilities	45.3	40.33	2.52	2.35	2.12	2.94
Total Liabilities	53.07	46.9	10.17	6.02	5.25	9.03
Total Debt	47.45	41.84	1.18	2.72	2.9	6.08
Debt Growth	4602.97%	3440.02%	-56.59%	-6.04%	-52.34%	59.37%
Retained Earnings	-193.63	-186.98	-165.3	-140.7	-18.14	-131.46
Comprehensive Income	0	0	0	0	0	0.27
Shareholders' Equity	-3.41	2.23	12.11	25.5	7.66	5.09
Net Cash / Debt	-38.24	-30.17	14.36	14.26	-1.27	-2.82
Net Cash / Debt Growth	-	-	0.68%	-	-	-
Net Cash Per Share	-7.07	-5.68	4.71	6.59	-1.44	-39.25
Working Capital	-1.6	3.03	6.03	15.09	-1.39	-0.03
Book Value Per Share	-0.63	0.42	3.97	11.78	8.71	70.83

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).